Nuveen Asset Management, LLC Adma Biologics, Inc. Transaction History
Nuveen Asset Management, LLC
- $334 Billion
- Q2 2024
A detailed history of Nuveen Asset Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 8,925,138 shares of ADMA stock, worth $173 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,925,138
Previous 10,461,376
14.68%
Holding current value
$173 Million
Previous $69 Million
44.52%
% of portfolio
0.03%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$362 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$281 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$255 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$156 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.82MShares$132 Million0.08% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.81B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...